NCT02484482View on ClinicalTrials.gov

Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Dyslipidemia
Interventions
DRUG

CKD-519 200mg / Fasting, Standard Meal, High Fat Meal

Trial Locations (1)

120-752

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY